Mavrilimumab, a GMCSF-R antibody shows promising results for giant cell arteritis in a phase 2 RCT. A late-breaking abstract from Cid et al. #ACR20 >FB

📢 Fresh air on environmental triggers in #GCA: 💥 Short-term exposure to PM10 pollutants increases GCA risk, especially in the elderly 👵🏻👴🏼 ⏳Association stronger in case of chronic exposure ➡️ Check out our article here: doi.org/10.1002/acr.25… Giovanni Adami Alessandro Tomelleri

🚨 What if a single DNA typo could inflame the body and outcompete healthy blood cells? 🧬 This happens in #VEXAS syndrome. In our paper out today in Nature Medicine we show how. 📖 Here: rb.gy/300drs 👇 A story of inflammation, clonal warfare and #CRISPR editing 🧵